AAIC 2017 | Different treatments for different phenotypes?
While it is possible that different molecules could be effective in treating alternative forms of Alzheimer’s disease with different phenotypes, our understanding of how this could be applied in the field is still extremely limited. Chiadi Onyike, MD from Johns Hopkins University, Baltimore, MD speaks to us about how identifying the vulnerabilities of susceptible regions of the brain may further our comprehension, and could lead to new, targeted treatments. This interview was recorded at the 2017 Alzheimer’s Association International Conference (AAIC) held in London, UK.
Get great new content delivered to your inboxSign up